SW – Smurfit WestRock plc

SW — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.74

Margin Of Safety %

Put/Call OI Ratio

0.57

EPS Next Q Diff

0.27

EPS Last/This Y

1.05

EPS This/Next Y

0.84

Price

38.24

Target Price

56.49

Analyst Recom

1.3

Performance Q

-1.26

Upside

20.8%

Beta

1.06

Ticker: SW

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	SW	42.1	0.51	0.16	9484
2026-03-10	SW	42.76	0.48	0.13	9523
2026-03-11	SW	42.18	0.47	0.63	9561
2026-03-12	SW	39.72	0.47	0.32	9572
2026-03-13	SW	39.71	0.47	0.36	9572
2026-03-17	SW	40.08	0.49	0.30	9928
2026-03-18	SW	38.57	0.49	9.35	9975
2026-03-19	SW	36.94	0.51	4.27	10134
2026-03-20	SW	36.11	0.48	3.00	9997
2026-03-23	SW	38.69	0.60	0.15	8158
2026-03-24	SW	39.86	0.60	0.40	8236
2026-03-25	SW	40.66	0.60	0.21	8621
2026-03-26	SW	40.43	0.60	0.65	8638
2026-03-27	SW	39.42	0.60	0.12	8701
2026-03-30	SW	38.24	0.57	0.04	9095
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

15 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	SW	42.10	-48.9	916.3	2.40
2026-03-10	SW	42.76	-48.9	956.3	2.40
2026-03-11	SW	42.17	-48.9	930.7	2.40
2026-03-12	SW	39.72	-48.9	851.9	2.40
2026-03-13	SW	39.75	-48.9	943.0	2.40
2026-03-17	SW	40.10	-48.9	953.0	2.40
2026-03-18	SW	38.55	-48.9	880.7	2.40
2026-03-19	SW	36.94	-48.9	986.7	2.40
2026-03-20	SW	36.11	-48.9	1006.3	2.40
2026-03-23	SW	38.69	-51.5	1191.1	2.38
2026-03-24	SW	39.86	-51.5	1123.6	2.38
2026-03-25	SW	40.69	-51.5	1201.6	2.38
2026-03-26	SW	40.45	-51.5	1155.4	2.38
2026-03-27	SW	39.47	-49.7	1109.2	2.39
2026-03-30	SW	38.24	-49.7	1093.9	2.39
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

15 items 1 of 1

16 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-06	SW	-2.36	-1.63	5.29
2026-03-09	SW	-2.36	-1.75	5.29
2026-03-10	SW	-2.36	-1.75	5.29
2026-03-11	SW	-2.36	-1.75	5.09
2026-03-12	SW	-2.36	-1.75	5.09
2026-03-13	SW	-2.36	-1.75	5.09
2026-03-17	SW	-2.36	-1.85	5.09
2026-03-18	SW	-2.36	-1.85	5.09
2026-03-19	SW	-2.36	-1.85	5.09
2026-03-20	SW	-2.36	-1.85	5.09
2026-03-23	SW	-2.36	-1.84	5.09
2026-03-24	SW	-2.36	-1.84	5.09
2026-03-25	SW	-2.36	-1.84	5.74
2026-03-26	SW	-2.36	-1.84	5.74
2026-03-27	SW	-2.36	-1.84	5.74
2026-03-30	SW	-2.36	-1.83	5.74
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

16 items 1 of 1

Last Quarter Act. EPS

0.34

Avg. EPS Est. Current Quarter

0.42

Avg. EPS Est. Next Quarter

0.61

Insider Transactions

-2.36

Institutional Transactions

-1.83

Beta

1.06

Average Sales Estimate Current Quarter

7533

Average Sales Estimate Next Quarter

7907

Fair Value

56.51

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

36.3

Max Drawdown 5-Year %

-54.4

Target Price

56.49

P/E

28.89

Forward P/E

11.97

PEG

0.55

P/S

0.64

P/B

1.09

P/Free Cash Flow

16.15

EPS

1.32

Average EPS Est. Cur. Y

2.39

EPS Next Y. (Est.)

3.23

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

2.24

Relative Volume

0.86

Return on Equity vs Sector %

-13

Return on Equity vs Industry %

0.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

1093.9

◆ SW Consumer Cyclical

$38.25

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

12/25

Volume

4/15

Valuation

18/20

TP/AR

2/10

Options

5/10

RSI

38.4

Range 1M

21.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

16/30

Estimates

4/20

Inst/Vol

0/15

Options

8/10

EPS Yr

22.8%

EPS NY

26.9%

52W%

28.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +121.7% upside

Quality

3/30

Valuation

26/30

Growth

13/25

Stability

4/10

LT Trend

4/5

Upside

+121.7%

Quality

MoS

48%

Smurfit WestRock plc

Sector: Consumer Cyclical

Industry: Packaging & Containers

Employees: 97000

Smurfit Westrock Plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in North America, South America, Europe, Asia, Africa, Australia, and internationally. The company produces containerboard and paperboard; packaging of corrugated containers; consumer packaging; and offers solid board, kraft paper, and graphic board, as well as other packaging products, such as solidboard packaging, paper sacks and bag-in-box. It produces linerboard and corrugated medium and paperboard; and other paper-based packaging, such as folding cartons, inserts, labels and displays. The company primarily serves food and beverage, healthcare, beauty and personal care, garden, consumer goods, industrial, and foodservice markets. It markets its products through its own sales force, independent sales representatives, and independent distributors. Smurfit Westrock Plc was founded in 1934 and is headquartered in Dublin, Ireland.

Latest News

—

Caricamento notizie per SW…

stock quote shares SW – Smurfit WestRock plc Stock Price stock today

news today SW – Smurfit WestRock plc stock forecast ,stock prediction 2023 2024 2025

marketwatch SW – Smurfit WestRock plc yahoo finance google finance

stock history SW – Smurfit WestRock plc invest stock market

stock prices SW premarket after hours

ticker SW fair value insiders trading

MURA – Mural Oncology plc

MURA — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.04

Target Price

Analyst Recom

Performance Q

-1.45

Upside

N/A

Beta

2.88

Ticker: MURA

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-03	MURA	2.04	N/A	N/A	0
2026-03-04	MURA	2.04	N/A	N/A	0
2026-03-06	MURA	2.04	N/A	N/A	0
2026-03-09	MURA	2.04	N/A	N/A	0
2026-03-10	MURA	2.04	N/A	N/A	0
2026-03-11	MURA	2.04	N/A	N/A	0
2026-03-12	MURA	2.04	N/A	N/A	0
2026-03-13	MURA	2.04	N/A	N/A	0
2026-03-17	MURA	2.04	N/A	N/A	0
2026-03-18	MURA	2.04	N/A	N/A	0
2026-03-20	MURA	2.04	N/A	N/A	0
2026-03-25	MURA	2.04	N/A	N/A	0
2026-03-26	MURA	2.04	N/A	N/A	0
2026-03-27	MURA	2.04	N/A	N/A	0
2026-03-30	MURA	2.04	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.62

Institutional Transactions

-16.45

Beta

2.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.8

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for MURA

MURA

Latest News

—

Caricamento notizie per MURA…

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

MDT – Medtronic Plc

MDT — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

1.3

Margin Of Safety %

Put/Call OI Ratio

0.59

EPS Next Q Diff

0.01

EPS Last/This Y

0.15

EPS This/Next Y

0.45

Price

85.77

Target Price

111.71

Analyst Recom

1.84

Performance Q

-11.17

Upside

-8.1%

Beta

0.76

Ticker: MDT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	MDT	98.77	0.53	0.54	149479
2026-03-03	MDT	96.71	0.53	0.29	152029
2026-03-04	MDT	95.6	0.53	0.49	156329
2026-03-05	MDT	93	0.52	0.43	159219
2026-03-06	MDT	90.85	0.50	0.28	161572
2026-03-09	MDT	91.34	0.51	0.30	150393
2026-03-10	MDT	89.89	0.50	0.80	150202
2026-03-11	MDT	88.96	0.49	0.57	153974
2026-03-12	MDT	87.4	0.49	1.10	157600
2026-03-13	MDT	87.38	0.49	1.08	157600
2026-03-17	MDT	88.45	0.50	0.57	163462
2026-03-18	MDT	87.19	0.50	3.98	166636
2026-03-19	MDT	86.87	0.54	0.63	171556
2026-03-20	MDT	86.18	0.52	0.61	170210
2026-03-23	MDT	87.19	0.67	0.26	113317
2026-03-24	MDT	86.57	0.63	0.64	120501
2026-03-25	MDT	87.91	0.62	0.60	124601
2026-03-26	MDT	87.68	0.62	0.18	127966
2026-03-27	MDT	87.12	0.63	0.34	129418
2026-03-30	MDT	85.77	0.59	0.25	122873
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	MDT	98.08	3.0	2012.6	5.65
2026-03-03	MDT	96.74	2.9	1882.5	5.65
2026-03-04	MDT	95.58	2.9	1898.6	5.65
2026-03-05	MDT	92.99	2.9	1787.6	5.65
2026-03-06	MDT	90.85	2.9	1818.1	5.65
2026-03-09	MDT	91.35	2.9	2016.5	5.65
2026-03-10	MDT	89.90	2.9	1870.4	5.65
2026-03-11	MDT	88.97	2.9	1910.0	5.65
2026-03-12	MDT	87.39	2.9	1857.2	5.65
2026-03-13	MDT	87.14	2.9	1962.2	5.65
2026-03-17	MDT	88.45	2.6	1998.6	5.64
2026-03-18	MDT	87.21	2.6	1884.0	5.64
2026-03-19	MDT	86.86	2.6	464.5	5.64
2026-03-20	MDT	86.20	2.5	443.7	5.64
2026-03-23	MDT	87.20	2.5	557.3	5.64
2026-03-24	MDT	86.58	2.5	449.0	5.64
2026-03-25	MDT	87.90	2.5	575.6	5.64
2026-03-26	MDT	87.71	2.5	475.9	5.64
2026-03-27	MDT	87.11	2.5	451.5	5.64
2026-03-30	MDT	85.77	2.5	397.5	5.64
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	MDT	-2.76	0.35	1.35
2026-03-03	MDT	-2.76	0.35	1.35
2026-03-04	MDT	-2.76	0.35	1.35
2026-03-05	MDT	-2.76	0.35	1.35
2026-03-06	MDT	0	0.35	1.35
2026-03-09	MDT	0	0.33	1.35
2026-03-10	MDT	0	0.33	1.35
2026-03-11	MDT	0	0.33	1.20
2026-03-12	MDT	0	0.33	1.20
2026-03-13	MDT	0	0.33	1.20
2026-03-17	MDT	0	0.34	1.20
2026-03-18	MDT	0	0.34	1.20
2026-03-19	MDT	0	0.34	1.20
2026-03-20	MDT	0	0.34	1.20
2026-03-23	MDT	0	0.36	1.20
2026-03-24	MDT	0	0.36	1.20
2026-03-25	MDT	0	0.36	1.30
2026-03-26	MDT	0	0.36	1.30
2026-03-27	MDT	0	0.36	1.30
2026-03-30	MDT	0	0.35	1.30
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.36

Avg. EPS Est. Current Quarter

1.66

Avg. EPS Est. Next Quarter

1.37

Insider Transactions

Institutional Transactions

0.35

Beta

0.76

Average Sales Estimate Current Quarter

9647

Average Sales Estimate Next Quarter

9349

Fair Value

113.09

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

36.9

Max Drawdown 5-Year %

-45.1

Target Price

111.71

P/E

23.94

Forward P/E

14.09

PEG

2.36

P/S

3.1

P/B

2.25

P/Free Cash Flow

20.35

EPS

3.58

Average EPS Est. Cur. Y

5.64

EPS Next Y. (Est.)

6.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.05

Return on Equity vs Sector %

-18

Return on Equity vs Industry %

-2.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

397.5

◆ MDT Healthcare

$85.74

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

15/25

Volume

4/15

Valuation

20/20

TP/AR

3/10

Options

5/10

RSI

Range 1M

1.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

9/30

Estimates

8/20

Inst/Vol

3/15

Options

9/10

EPS Yr

2.9%

EPS NY

7.7%

52W%

23.9%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +43.8% upside

Quality

10/30

Valuation

20/30

Growth

7/25

Stability

7/10

LT Trend

4/5

Upside

+43.8%

Quality

MoS

32%

Medtronic plc.

Sector: Healthcare

Industry: Medical Devices

Employees: 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

MDT

Latest News

—

Caricamento notizie per MDT…

stock quote shares MDT – Medtronic Plc Stock Price stock today

news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDT – Medtronic Plc yahoo finance google finance

stock history MDT – Medtronic Plc invest stock market

stock prices MDT premarket after hours

ticker MDT fair value insiders trading

ITRM – Iterum Therapeutics Plc

ITRM — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.85

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.1

EPS Last/This Y

0.6

EPS This/Next Y

0.35

Price

0.07

Target Price

Analyst Recom

Performance Q

-76.67

Upside

-37,600.0%

Beta

3.42

Ticker: ITRM

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-03	ITRM	0.1482	N/A	N/A	0
2026-03-04	ITRM	0.1689	N/A	N/A	0
2026-03-06	ITRM	0.1673	N/A	N/A	0
2026-03-09	ITRM	0.18	N/A	N/A	0
2026-03-10	ITRM	0.1851	N/A	N/A	0
2026-03-11	ITRM	0.1744	N/A	N/A	0
2026-03-12	ITRM	0.1717	N/A	N/A	0
2026-03-13	ITRM	0.1711	N/A	N/A	0
2026-03-17	ITRM	0.1715	N/A	N/A	0
2026-03-18	ITRM	0.1746	N/A	N/A	0
2026-03-20	ITRM	0.1617	N/A	N/A	0
2026-03-25	ITRM	0.172	N/A	N/A	0
2026-03-26	ITRM	0.1747	N/A	N/A	0
2026-03-27	ITRM	0.0363	N/A	N/A	0
2026-03-30	ITRM	0.0719	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	ITRM	0.30	-	7.9	-0.66
2026-03-03	ITRM	0.15	-	12.0	-0.66
2026-03-04	ITRM	0.17	-	8.2	-0.66
2026-03-05	ITRM	0.17	-	8.8	-0.66
2026-03-06	ITRM	0.17	-	8.7	-0.66
2026-03-09	ITRM	0.18	-	8.8	-0.66
2026-03-10	ITRM	0.18	-	9.0	-0.66
2026-03-11	ITRM	0.17	-	9.3	-0.66
2026-03-12	ITRM	0.17	-	8.7	-0.66
2026-03-13	ITRM	0.17	-	8.8	-0.66
2026-03-17	ITRM	0.17	-	8.7	-0.66
2026-03-18	ITRM	0.18	-	8.7	-0.66
2026-03-19	ITRM	0.17	-	9.0	-0.66
2026-03-20	ITRM	0.16	-	9.0	-0.66
2026-03-23	ITRM	0.17	-	8.8	-0.66
2026-03-24	ITRM	0.17	-	8.8	-0.66
2026-03-25	ITRM	0.17	-	9.0	-0.66
2026-03-26	ITRM	0.17	-	8.7	-0.66
2026-03-27	ITRM	0.04	-	12.5	-0.66
2026-03-30	ITRM	0.07	-	8.8	-0.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	ITRM	1.46	0.68	3.34
2026-03-03	ITRM	1.46	0.68	3.34
2026-03-04	ITRM	1.46	0.68	3.34
2026-03-05	ITRM	1.46	0.68	3.34
2026-03-06	ITRM	1.46	0.68	3.34
2026-03-09	ITRM	1.46	0.68	3.34
2026-03-10	ITRM	1.46	0.68	3.34
2026-03-11	ITRM	1.46	0.68	3.90
2026-03-12	ITRM	1.46	0.68	3.90
2026-03-13	ITRM	1.46	0.68	3.90
2026-03-18	ITRM	1.46	0.68	3.90
2026-03-19	ITRM	1.46	0.68	3.90
2026-03-20	ITRM	1.46	0.68	3.90
2026-03-23	ITRM	1.46	0.66	3.90
2026-03-24	ITRM	1.46	0.66	3.90
2026-03-25	ITRM	1.46	0.66	5.85
2026-03-26	ITRM	1.46	0.66	5.85
2026-03-27	ITRM	1.46	0.66	5.85
2026-03-30	ITRM	1.46	0.66	5.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

1.46

Institutional Transactions

0.66

Beta

3.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.8

Max Drawdown 5-Year %

-99.9

Target Price

P/E

Forward P/E

PEG

P/S

9.53

P/B

P/Free Cash Flow

EPS

-0.75

Average EPS Est. Cur. Y

-0.66

EPS Next Y. (Est.)

-0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6913.08

Relative Volume

304.69

Return on Equity vs Sector %

337.8

Return on Equity vs Industry %

354.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.33

EBIT Estimation

8.8

◆ ITRM Healthcare

$0.07

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

4/25

Volume

3/15

Valuation

12/20

TP/AR

4/10

Options

0/10

RSI

29.7

Range 1M

24%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

14/30

Estimates

4/20

Inst/Vol

6/15

Options

0/10

EPS Yr

18%

EPS NY

67.1%

52W%

3.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +12757.1% upside

Quality

4/30

Valuation

16/30

Growth

14/25

Stability

7/10

LT Trend

1/5

Upside

+12757.1%

Quality

Iterum Therapeutics plc

Sector: Healthcare

Industry: Biotechnology

Employees: 9

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

ITRM

Latest News

—

Caricamento notizie per ITRM…

stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today

news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance

stock history ITRM – Iterum Therapeutics Plc invest stock market

stock prices ITRM premarket after hours

ticker ITRM fair value insiders trading

AMRN – Amarin Corp ADR

AMRN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.16

Margin Of Safety %

-21

Put/Call OI Ratio

0.29

EPS Next Q Diff

0.16

EPS Last/This Y

2.58

EPS This/Next Y

0.39

Price

13.94

Target Price

Analyst Recom

Performance Q

-1.34

Upside

-571.7%

Beta

0.78

Ticker: AMRN

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-03	AMRN	14.34	0.22	0.00	3902
2026-03-04	AMRN	14.56	0.22	0.00	3890
2026-03-06	AMRN	14.05	0.22	0.08	3910
2026-03-09	AMRN	14.65	0.23	0.00	3869
2026-03-10	AMRN	15.99	0.23	0.06	3830
2026-03-11	AMRN	16.34	0.22	0.00	4049
2026-03-12	AMRN	16.28	0.21	0.05	4164
2026-03-13	AMRN	16.37	0.21	0.05	4164
2026-03-17	AMRN	15.52	0.21	0.00	4193
2026-03-18	AMRN	14.95	0.21	0.00	4190
2026-03-20	AMRN	14.49	0.20	0.28	4419
2026-03-25	AMRN	14.72	0.31	0.13	2166
2026-03-26	AMRN	14.65	0.29	0.23	2382
2026-03-27	AMRN	14.44	0.28	0.63	2540
2026-03-30	AMRN	13.88	0.29	0.11	2555
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	AMRN	13.93	-	-	0.59
2026-03-03	AMRN	14.29	-	-	0.59
2026-03-04	AMRN	14.36	-	-	0.59
2026-03-05	AMRN	14.19	-	-	0.59
2026-03-06	AMRN	14.01	-	-	0.59
2026-03-09	AMRN	14.62	142.5	-	0.78
2026-03-10	AMRN	15.92	142.5	-	0.78
2026-03-11	AMRN	16.29	142.5	-	0.78
2026-03-12	AMRN	16.28	142.5	-	0.78
2026-03-13	AMRN	15.33	142.5	-	0.78
2026-03-17	AMRN	15.46	142.5	-	0.78
2026-03-18	AMRN	14.94	142.5	-	0.78
2026-03-19	AMRN	14.95	142.5	-	0.78
2026-03-20	AMRN	14.48	142.5	-	0.78
2026-03-23	AMRN	14.78	142.5	-	0.78
2026-03-24	AMRN	14.47	142.5	-	0.78
2026-03-25	AMRN	14.62	142.5	-	0.78
2026-03-26	AMRN	14.60	142.5	-	0.78
2026-03-27	AMRN	14.32	142.5	-	0.78
2026-03-30	AMRN	13.94	142.5	-	0.78
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	AMRN	0.00	-0.01	1.98
2026-03-03	AMRN	0.00	-0.01	1.98
2026-03-04	AMRN	0.00	-0.01	1.98
2026-03-05	AMRN	0.00	-0.01	1.98
2026-03-06	AMRN	0.00	-0.01	1.98
2026-03-09	AMRN	0.00	-0.01	1.98
2026-03-10	AMRN	0.00	-0.01	1.98
2026-03-11	AMRN	0.00	-0.01	2.11
2026-03-12	AMRN	0.00	-0.01	2.11
2026-03-13	AMRN	0.00	-0.01	2.11
2026-03-18	AMRN	0.00	0.02	2.11
2026-03-19	AMRN	0.00	0.02	2.11
2026-03-20	AMRN	0.00	0.02	2.11
2026-03-23	AMRN	0.00	0.02	2.11
2026-03-24	AMRN	0.00	0.02	2.11
2026-03-25	AMRN	0.00	0.02	2.16
2026-03-26	AMRN	0.00	0.02	2.16
2026-03-27	AMRN	0.00	0.02	2.16
2026-03-30	AMRN	0.00	0.02	2.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.01

Avg. EPS Est. Current Quarter

0.17

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

Institutional Transactions

0.02

Beta

0.78

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

11.08

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.4

Max Drawdown 5-Year %

-93.8

Target Price

P/E

Forward P/E

253.64

PEG

P/S

1.35

P/B

0.63

P/Free Cash Flow

EPS

-1.88

Average EPS Est. Cur. Y

0.78

EPS Next Y. (Est.)

1.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-18.19

Relative Volume

0.68

Return on Equity vs Sector %

-35.9

Return on Equity vs Industry %

-45.1

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.19

EBIT Estimation

◆ AMRN Healthcare

$13.95

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

14/25

Volume

9/15

Valuation

9/20

TP/AR

0/10

Options

8/10

RSI

39.4

Range 1M

33.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

22/30

Estimates

1/20

Inst/Vol

3/15

Options

8/10

EPS Yr

133.3%

EPS NY

83.3%

52W%

53.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +87.8% upside

Quality

5/30

Valuation

19/30

Growth

19/25

Stability

7/10

LT Trend

0/5

Upside

+87.8%

Quality

MoS

-21%

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 80

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN

Latest News

—

Caricamento notizie per AMRN…

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

ALKS – Alkermes plc

ALKS — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

12.62

Margin Of Safety %

Put/Call OI Ratio

1.13

EPS Next Q Diff

0.3

EPS Last/This Y

0.88

EPS This/Next Y

-0.28

Price

30.14

Target Price

43.53

Analyst Recom

1.41

Performance Q

5.83

Upside

66.0%

Beta

0.54

Ticker: ALKS

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-03	ALKS	29.19	1.00	23.00	5853
2026-03-04	ALKS	29.27	1.21	1.08	6501
2026-03-06	ALKS	28.63	1.30	0.74	6956
2026-03-09	ALKS	28.44	1.29	12.35	6999
2026-03-10	ALKS	27.74	1.31	3.94	7440
2026-03-11	ALKS	27.76	1.34	0.04	7634
2026-03-12	ALKS	27.66	1.23	1.00	7921
2026-03-13	ALKS	27.64	1.23	1.00	7921
2026-03-17	ALKS	27.67	1.15	0.18	8287
2026-03-18	ALKS	27.2	1.08	1.20	8498
2026-03-20	ALKS	28.17	1.08	1.44	8565
2026-03-25	ALKS	29.38	1.19	0.89	5451
2026-03-26	ALKS	29.93	1.17	0.08	5507
2026-03-27	ALKS	29.4	1.14	0.16	5601
2026-03-30	ALKS	30.14	1.13	0.04	5632
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	ALKS	30.27	-	-76.8	-0.67
2026-03-03	ALKS	29.19	-	-93.4	-0.67
2026-03-04	ALKS	29.27	-	-78.2	-0.67
2026-03-05	ALKS	28.32	-26.9	11.2	2.35
2026-03-06	ALKS	28.62	-26.9	26.6	2.35
2026-03-09	ALKS	28.45	-26.9	20.6	2.35
2026-03-10	ALKS	27.73	-26.9	13.6	2.35
2026-03-11	ALKS	27.76	-26.9	23.0	2.35
2026-03-12	ALKS	27.66	-26.9	21.2	2.35
2026-03-13	ALKS	27.77	-26.9	24.5	2.35
2026-03-17	ALKS	27.66	-26.9	18.3	2.35
2026-03-18	ALKS	27.21	-26.9	16.8	2.35
2026-03-19	ALKS	28.41	-26.9	80.6	2.35
2026-03-20	ALKS	28.15	-26.9	76.8	2.35
2026-03-23	ALKS	27.69	-26.9	69.8	2.35
2026-03-24	ALKS	28.41	-26.9	80.7	2.35
2026-03-25	ALKS	29.36	-26.9	95.2	2.35
2026-03-26	ALKS	29.93	-26.9	103.8	2.35
2026-03-27	ALKS	29.41	-26.9	95.9	2.35
2026-03-30	ALKS	30.14	-26.9	106.9	2.35
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	ALKS	-3.02	3.65	10.91
2026-03-03	ALKS	-3.02	3.65	10.91
2026-03-04	ALKS	-3.02	3.65	10.91
2026-03-05	ALKS	-3.74	3.65	10.91
2026-03-06	ALKS	-3.74	3.65	10.91
2026-03-09	ALKS	-3.74	3.61	10.91
2026-03-10	ALKS	-3.74	3.61	10.91
2026-03-11	ALKS	-3.74	3.61	11.14
2026-03-12	ALKS	-3.74	3.61	11.14
2026-03-13	ALKS	-3.74	3.61	11.14
2026-03-18	ALKS	-3.74	3.61	11.14
2026-03-19	ALKS	-3.74	3.61	11.14
2026-03-20	ALKS	-3.74	3.61	11.14
2026-03-23	ALKS	-3.74	3.60	11.14
2026-03-24	ALKS	-3.74	3.60	11.14
2026-03-25	ALKS	-3.74	3.60	12.62
2026-03-26	ALKS	-3.74	3.60	12.62
2026-03-27	ALKS	-3.74	3.60	12.62
2026-03-30	ALKS	-3.74	3.61	12.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.34

Avg. EPS Est. Current Quarter

0.21

Avg. EPS Est. Next Quarter

0.64

Insider Transactions

-3.74

Institutional Transactions

3.61

Beta

0.54

Average Sales Estimate Current Quarter

358

Average Sales Estimate Next Quarter

463

Fair Value

37.54

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

17.3

Max Drawdown 5-Year %

-33.2

Target Price

43.53

P/E

21.05

Forward P/E

41.18

PEG

P/S

3.4

P/B

2.74

P/Free Cash Flow

10.46

EPS

1.43

Average EPS Est. Cur. Y

2.35

EPS Next Y. (Est.)

2.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.37

Relative Volume

1.19

Return on Equity vs Sector %

-14.2

Return on Equity vs Industry %

6.1

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.19

EBIT Estimation

106.9

◆ ALKS Healthcare

$30.15

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

8/25

Volume

4/15

Valuation

20/20

TP/AR

2/10

Options

3/10

RSI

55.1

Range 1M

88%

Sup Dist

4.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

11/30

Estimates

4/20

Inst/Vol

7/15

Options

6/10

EPS Yr

-133.5%

EPS NY

252.8%

52W%

44%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +86.4% upside

Quality

19/30

Valuation

23/30

Growth

7/25

Stability

8/10

LT Trend

2/5

Upside

+86.4%

Quality

MoS

25%

Alkermes plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 2050

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS

Latest News

—

Caricamento notizie per ALKS…

stock quote shares ALKS – Alkermes plc Stock Price stock today

news today ALKS – Alkermes plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ALKS – Alkermes plc yahoo finance google finance

stock history ALKS – Alkermes plc invest stock market

stock prices ALKS premarket after hours

ticker ALKS fair value insiders trading

No more stocks to show

SW – Smurfit WestRock plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

MURA – Mural Oncology plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MURA

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y